{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:36:58Z","timestamp":1785188218923,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1124\/dmd.119.088674","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T03:55:33Z","timestamp":1584676533000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Impact of Breast Cancer Resistance Protein (BCRP\/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers"],"prefix":"10.1016","volume":"48","author":[{"given":"Iichiro","family":"Kawahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoyo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.088674_bib1","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.119.088674_bib2","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1124\/dmd.111.040881","article-title":"Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice","volume":"39","author":"\u00c1lvarez","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1124\/dmd.119.088674_bibib44","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.119.088674_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.apsb.2016.09.005","article-title":"Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles","volume":"7","author":"B Shekhawat","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.119.088674_bib4","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.119.088674_bibib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0005-2736(90)90309-C","article-title":"Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2","volume":"1027","author":"Dantzig","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.119.088674_bib5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.bjp.0702703","article-title":"Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates","volume":"127","author":"Dautrey","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib6","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.119.088674_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/AAC.30.3.444","article-title":"Absolute oral bioavailability of ciprofloxacin","volume":"30","author":"Drusano","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.119.088674_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.107.034751","article-title":"Effect of breast cancer resistance protein (Bcrp\/Abcg2) on the disposition of phytoestrogens","volume":"72","author":"Enokizono","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1211\/jpp.59.7.0001","article-title":"Prediction of human pharmacokinetics--gastrointestinal absorption","volume":"59","author":"Fagerholm","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.119.088674_bibib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-3565(24)38246-1","article-title":"Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding","volume":"289","author":"Fisher","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.088674_bibib48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1476-5381.2009.00620.x","article-title":"\u03b4-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1)","volume":"159","author":"Fr\u00f8lund","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1124\/dmd.119.088674_bib10","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1021\/acs.molpharmaceut.6b00941","article-title":"Transport-glucuronidation classification system and PBPK modeling: new approach to predict the impact of transporters on disposition of glucuronides","volume":"14","author":"Ge","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.088674_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejps.2009.03.008","article-title":"Impact of carriers in oral absorption: permeation across Caco-2 cells for the organic anions estrone-3-sulfate and glipizide","volume":"37","author":"Gram","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.088674_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/dmd.106.011411","article-title":"Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta","volume":"35","author":"Grube","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib13","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1124\/dmd.111.038323","article-title":"Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2)","volume":"39","author":"Haslam","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.drudis.2013.08.013","article-title":"Drug dissolution: significance of physicochemical properties and physiological conditions","volume":"18","author":"Jambhekar","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.119.088674_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00280-006-0244-3","article-title":"Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties","volume":"59","author":"Jekerle","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.21827","article-title":"In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques","volume":"119","author":"Jekerle","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.119.088674_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.10100","article-title":"Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization","volume":"97","author":"Kage","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.119.088674_bib19","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/cbdv.200900054","article-title":"Measurement and prediction of oral absorption","volume":"6","author":"Keldenich","year":"2009","journal-title":"Chem Biodivers"},{"key":"10.1124\/dmd.119.088674_bib20","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1271\/bbb.130404","article-title":"Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes","volume":"77","author":"Kobayashi","year":"2013","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/dmd.119.088674_bibib55","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1248\/bpb.b17-00563","article-title":"Influence of Physicochemical Properties and PEG Modification of Magnetic Liposomes on Their Interaction with Intestinal Epithelial Caco-2 Cells","volume":"40","author":"Kono","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.119.088674_bib21","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1200\/JCO.2002.12.116","article-title":"Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918","volume":"20","author":"Kruijtzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.119.088674_bib22","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1476-5381.2012.01887.x","article-title":"Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP","volume":"166","author":"Kusuhara","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1124\/dmd.119.088674_bibib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-013-9456-8","article-title":"Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements","volume":"15","author":"Larregieu","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.088674_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.119.088674_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejps.2018.01.002","article-title":"The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human organic anion\/cation transporters, organic anion transporting polypeptides and oligopeptide transporters in in vitro models","volume":"115","author":"Lu","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.088674_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp060082j","article-title":"Identification of influx transporter for the quinolone antibacterial agent levofloxacin","volume":"4","author":"Maeda","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.088674_bib27","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.119.088674_bib28","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj070112","article-title":"Role of the breast cancer resistance protein (ABCG2) in drug transport","volume":"7","author":"Mao","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.088674_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/dmd.113.051680","article-title":"In vivo assessment of the impact of efflux transporter on oral drug absorption using portal vein-cannulated rats","volume":"41","author":"Matsuda","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib31","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1124\/mol.104.010439","article-title":"The breast cancer resistance protein (BCRP\/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin","volume":"67","author":"Merino","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib32","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.119.088674_bibib49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejpb.2012.03.007","article-title":"Carrier-mediated \u03b3-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers","volume":"81","author":"Nielsen","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/dmd.119.088674_bibib52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1023\/A:1010932126662","article-title":"Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide","volume":"18","author":"Ramanathan","year":"2001","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.088674_bib33","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.106.009530","article-title":"Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells","volume":"34","author":"Sai","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bibib47","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1124\/dmd.108.022335","article-title":"The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells","volume":"36","author":"Siissalo","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088674_bib34","doi-asserted-by":"crossref","first-page":"22644","DOI":"10.1074\/jbc.M212399200","article-title":"ABCG2 transports sulfated conjugates of steroids and xenobiotics","volume":"278","author":"Suzuki","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.088674_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11095-009-0026-9","article-title":"Model analysis of the concentration-dependent permeability of P-gp substrates","volume":"27","author":"Tachibana","year":"2010","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.088674_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","article-title":"Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers","volume":"299","author":"Taipalensuu","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.088674_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11095-004-1884-9","article-title":"Characterization of polarized expression of point- or deletion-mutated human BCRP\/ABCG2 in LLC-PK1 cells","volume":"22","author":"Takada","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.088674_bibib54","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1476-5381.1994.tb17099.x","article-title":"Substrate specificity of the di\/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H+-coupled absorption","volume":"113","author":"Thwaites","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1025001131513","article-title":"Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.088674_bibib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jphp.12006","article-title":"Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1)","volume":"65","author":"Voigt","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jps.21010","article-title":"Variability in Caco-2 and MDCK cell-based intestinal permeability assays","volume":"97","author":"Volpe","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.088674_bibib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(99)00182-0","article-title":"Human Na+-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant","volume":"1461","author":"Wang","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.119.088674_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2011.10.004","article-title":"Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers","volume":"672","author":"Wright","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.119.088674_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/mp050088t","article-title":"A 96-well efflux assay to identify ABCG2 substrates using a stably transfected MDCK II cell line","volume":"3","author":"Xiao","year":"2006","journal-title":"Mol Pharm"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407884X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407884X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.088674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:25:56Z","timestamp":1739957156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562407884X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S009095562407884X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.088674","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Breast Cancer Resistance Protein (BCRP\/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.088674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}